Based on 784 businesses audited.
Medical Devices, Pharma & Biotech Reputation: TAGRISSO (AstraZeneca) (tagrisso.com)
This site is a ‘regulatory fortress built on a template swamp.’ While the drug’s clinical substance is undeniable and well-cited, the digital delivery is plagued by unfinished placeholders and absurd H1 errors like the ‘pancakes’ slogan. It currently functions as a compliant but lazy brochure that fails to provide the authoritative patient-centered experience it promises.
Medical Devices, Pharma & Biotech Reputation: TAGRISSO (AstraZeneca) (tagrisso.com)
The site content perfectly aligns with the Pharma & Biotech category, specifically focusing on oncology and targeted therapies for EGFR+ NSCLC. It utilizes heavy regulatory-required documentation such as Important Safety Information (ISI) and cites peer-reviewed studies (Sholl et al., D’Angelo et al.), confirming its status as a pharmaceutical product site.
“The score of 55 is driven primarily by the 'Identity and Authority' and 'Information Density' pillars due to the catastrophic presence of placeholder text and nonsensical H1 headers. While the clinical data is highly substantive (lowering the potential score), the technical execution is so indicative of a generic template failure that it introduces significant 'Bullshit' via neglect. The lack of structured data and the presence of dummy names like 'Name X' are the primary credibility killers.”